The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience
- 31 January 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 194 (1), 49-56
- https://doi.org/10.1016/j.ajog.2005.06.048
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel–platinumEuropean Journal of Surgical Oncology, 2005
- Critical evaluation of secondary cytoreduction in recurrent ovarian cancerGynecologic Oncology, 2004
- Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian CancerGynecologic Oncology, 2001
- Complete Salvage Surgical Cytoreduction Improves Further Survival of Patients with Late Recurrent Ovarian CancerGynecologic Oncology, 2000
- Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancerEuropean Journal of Surgical Oncology, 2000
- Recurrent ovarian carcinoma: Is there a place for surgery?Seminars in Surgical Oncology, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective studyCancer, 1995
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerGynecologic Oncology, 1989